Page last updated: 2024-09-03

n,n-dimethylarginine and Ventricular Dysfunction

n,n-dimethylarginine has been researched along with Ventricular Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berti, F; Berti, M; Bianchi, M; Bonomo, S; De Gennaro Colonna, V; Ferrario, P; Guazzi, M; Manfredi, B; Muller, EE; Rossoni, G	1

Other Studies

1 other study(ies) available for n,n-dimethylarginine and Ventricular Dysfunction

Article	Year
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats. European journal of pharmacology, 2007, Feb-28, Volume: 557, Issue:2-3 Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Arginine; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Heart Rate; Male; Myocardial Reperfusion Injury; Nitrates; Nitrites; Perfusion; Rats; Rats, Wistar; RNA, Messenger; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Dysfunction	2007

Article

Year

Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.

European journal of pharmacology, 2007, Feb-28, Volume: 557, Issue:2-3

Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Arginine; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Heart Rate; Male; Myocardial Reperfusion Injury; Nitrates; Nitrites; Perfusion; Rats; Rats, Wistar; RNA, Messenger; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Dysfunction

2007